February 10, 2021
11/02/2021
February 10, 2021
LA JOLLA, CA A sensor protein called PIEZO1, closely related to the protein that enables our sense of touch, plays an unexpected and important role in regulating iron levels in the body, according to a study from scientists at Scripps Research and Howard Hughes Medical Institute (HHMI).
The scientists also found that a mildly overactive form of PIEZO1, which is very common in people of African background, is associated with higher levels of iron and may be a cause of iron-related health problems.
The findings, reported in Cell, advance the scientific understanding of how the body manages its iron levels, and point to the possibility of better treatments for iron overload, which can damage blood vessels, the liver, and the heart, and has been associated with hypertension and diabetes. The linkage of a common gene variant to higher iron levels may also lead to better medical surveillance of iron overload, perhaps especially in people of African heritage.
Iron overload is a rare and underappreciated medical condition, and while its genetic roots have been well studied in people of European descent, much less has been known about those genetic roots in African populations says Shang Ma, PhD, a postdoctoral fellow at Scripps Research and the study's first author.
Ma is member of the laboratory of Ardem Patapoutian, PhD, a professor in the Department of Neuroscience at Scripps Research and an HHMI investigator, as well as the study's senior author. Patapoutian and his lab identified PIEZO1 and its close cousin PIEZO2 in 2010.
The two PIEZO proteins, which are unlike any other known protein, form propeller-shaped sensors that are embedded in the outer membranes of cells. These sensors admit flows of charged molecules, called ions, when they are mechanically stretched, pressed, or otherwise distorted beyond a certain threshold.
PIEZO2 works in sensory nerves that detect touch, in the bladder to sense fullness, and around joints to enable proprioception, which enables us to sense the position of our body and limbs. PIEZO1 is known to play a role in the development of blood vessels, the heart, bone, and immune cells, and helps red blood cells regulate their internal volumes.
A surprise factor in iron metabolism
In the study, Ma and other members of Patapoutian's team started by examining a set of PIEZO1 gene mutations that cause a rare blood disorder called hereditary xerocytosis, also known as HX. In a 2018 study, the team had shown that these mutations which lead to red blood cell dehydration protect the cells from malaria parasites.
But people with HX also tend to have iron overload, though the reason wasn't clear. In the new set of experiments involving rodents, the researchers showed how iron overload results from PIEZO1 mutations. Surprisingly, it's not due to the mutations' effect on red blood cells, but rather their effect on large white blood cells called macrophages.
Macrophages, whose name literally means big eaters, help regulate the numbers of red blood cells in the blood by consuming the older cells. Macrophages also are studded with PIEZO1 mechanosensors, which help guide them as they engulf other cells.
The mutations linked to HX cause PIEZO1 sensors to keep their ion channels open longer than normal, making the macrophages gobble red blood cells at an abnormally high rate. Red blood cells are the largest reservoir of iron in the body, and this faster pace of consumption disrupts the usual hormonal regulation of iron. As a result, iron levels rise.
A common risk factor for iron overload
In their 2018 study, Patapoutian's team identified a different variant of the PIEZO1 gene carried by up to a third of people of African background, making it much more common than HX. This variant also has a mild PIEZO1-overactivating effect and is associated with protection against malaria.
As part of the new study, the team tested blood that had been donated at collection centers by 333 self-identifying African Americans. They found that, as expected, 32.7 percent were carriers of this previously identified PIEZO1 variant. By the usual indirect measures of iron in blood tests, which examine levels of the iron transporter transferrin and the iron-sequestering protein ferritin, these carriers did indeed have significantly higher iron levels than non-carriers, on average. The effect seemed evident only among those older than 40, but it was a strong effect. In the over-40 age group, carriers were about 12 times more likely than non-carriers to have abnormally high ferritin levels.
The findings open up a broad new avenue of investigation into iron metabolism and iron overload, the researchers say, and conceivably could help explain and might lead to better solutions for some of the persistent health disparities between African Americans and other ethnicities in the U.S.
More clinical work is needed to extend our studies, but this apparent new risk factor for age-onset iron overload in such a large population may have profound clinical consequences, Patapoutian says.
A role of PIEZO1 in iron metabolism in mice and humans was authored by Shang Ma, Adrienne Dubin, Yunxiao Zhang, Seyed Ali Reza Mousavi, Yu Wang, Adam Coombs, Meaghan Loud, Immacolata Andolfo, and Ardem Patapoutian.
Funding was provided by the National Institutes of Health (R35 NS105067, R01 DE022358) and HHMI.
Neuroscience Patapoutian, Ardem
LINK: | https://www.scripps.edu/news-and-events/press-room/2021/20210210-patap... |
See more stories from scripps |
More from Scripps
20/04/2024
April 19, 2024
New copper-catalyzed C-H activation strategy from Scripps Research Two-mode reactions inspired by human detox enzymes offer powerful new tools for drug discover...
12/04/2024
April 11, 2024
Scripps Research chemists devise easier new method for making a common type of building block for drugs Scientists transform simple linear amines into saturated...
06/04/2024
April 05, 2024
A simple, inexpensive way to make carbon atoms bind together A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules,...
04/04/2024
April 03, 2024
Developing a vaccine for the zombie drug xylazine Scripps Research chemical biologists design an early proof-of-concept vaccine that could lead to the first...
30/03/2024
March 29, 2024
How blocking a neural receptor responsible for addiction could reduce alcohol use A Scripps Research team found that a new therapeutic that targets the kappa op...
13/03/2024
March 13, 2024
New computational strategy boosts the ability of drug designers to target proteins inside the membrane Customized-design approach could streamline the design of...
29/02/2024
February 29, 2024
Scripps Research scientists reveal how first cells could have formed on Earth New phospholipid discovery brings researchers closer to understanding how primordi...
29/02/2024
February 28, 2024
How molecular handedness emerged in early biology Scripps Research chemists fill a major gap in origin-of-life theories. February 28, 2024 LA JOLLA, CA Mole...
22/02/2024
February 21, 2024
Snaking toward a universal antivenom Scripps Research scientists discovered antibodies that protect against a host of lethal snake venoms. February 21, 2024 ...
06/02/2024
February 06, 2024
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases AbbVie...
26/01/2024
January 25, 2024
Re-energizing mitochondria to treat Alzheimer's disease Scripps Research team restored neuron-to-neuron connections in human cells. January 25, 2024 LA JO...
24/01/2024
January 04, 2024
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health For the last century, institute leaders and renowned scie...
23/01/2024
January 23, 2024
New technology lets researchers track brain cells' off switches The method could shed light on what goes awry in numerous brain conditions when neurons ar...
09/01/2024
January 08, 2024
Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines The ALSAM Foundation, founded by the Skaggs family, provides lasting g...
04/01/2024
January 03, 2024
Life science entrepreneur Gene Lay joins Scripps Research Board of Directors Lay, founder of the global biotech company BioLegend, brings invaluable experience ...
21/12/2023
December 20, 2023
Taming a plant-derived toxin Scripps Research team modifies the traditional poison picrotoxinin for potential neurological drugs and anti-parasite treatments. ...
19/12/2023
December 18, 2023
Scripps Research Executive Vice President Eric Topol gives TED talk on transformative power of AI in medicine Topol provides an overview of how AI models can i...
13/12/2023
December 12, 2023
New AI-powered algorithm could better assess people's risk of common heart condition Early detection of atrial fibrillation can reduce the risk of stroke an...
07/12/2023
December 06, 2023
Nanoparticle flu vaccine design shows promise in early tests Scripps Research-designed vaccine could provide broad, enduring protection against influenza A str...
16/11/2023
November 15, 2023
Numerous Scripps Research scientists named Highly Cited Researchers Clarivate's annual, global list represents researchers who have demonstrated significant...
07/11/2023
November 06, 2023
Multiple sclerosis drug invented at Scripps Research slows long-term devastating disease progression Late-breaking data reinforces the effectiveness and safety ...
05/10/2023
October 04, 2023
Keren Lasker named a 2023 Moore Inventor Fellow The prestigious award will support Lasker's inventive research in membraneless organelles and their applica...
22/09/2023
September 21, 2023
Michael Bollong named a 2023 Amgen Young Investigator The prestigious award will support Bollong's research identifying new molecular targets and therapeuti...
09/09/2023
September 08, 2023
Philip Dawson receives 2024 American Chemical Society National Award Dawson is honored with the Arthur C. Cope Late Careers Scholar Award for his foundational c...
07/09/2023
September 06, 2023
Scripps Research chemists devise a method for C-H activation of alcohols The method represents a new toolkit for making drugs and other compounds. September 06...
31/08/2023
August 30, 2023
Scripps Research receives $1.5M to surveil infectious disease threats in wastewater Bill & Melinda Gates Foundation award to support the development of multi-pa...
16/08/2023
August 16, 2023
How cold temperatures trigger the brain to boost appetite Scripps Research scientists' discovery could lead to new weight loss and metabolic health treatmen...
08/08/2023
August 07, 2023
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study Scripps Research-developed antibody therapy...
04/08/2023
August 03, 2023
How sensory neurons impact the gut Scripps Research scientists show that the receptor PIEZO2 in sensory neurons controls gut motility and transit time, which a...
26/07/2023
July 26, 2023
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets The expanded strategic collaboration will advan...
23/07/2023
July 21, 2023
Scripps Research scientists develop AI-based tracking and early-warning system for viral pandemics Machine-learning system effectively predicts emergence of pro...
19/07/2023
July 19, 2023
Monitoring T cells may allow prevention of type 1 diabetes Scripps Research study shows that analyzing T cells in blood samples could be used to select at-risk ...
19/07/2023
July 18, 2023
Scripps Research mourns passing of leading organic chemist Albert Eschenmoser Eschenmoser pioneered key reactions in synthetic chemistry and shaped the understa...
15/06/2023
June 14, 2023
Scripps Research awarded $46.8 million by NIH to promote human health through innovative translational science and training The Translational Institute is harne...
13/06/2023
June 13, 2023
Scripps Research's Danielle Grotjahn named 2023 Pew Scholar in the Biomedical Sciences The award will support Grotjahn's study of how cells assemble the...
31/05/2023
May 31, 2023
Crossing the ring: new method enables C-H activation across saturated carbocycles Scripps Research chemists add another powerful tool to their molecular editin...
24/05/2023
May 23, 2023
Scripps Research develops behind-the-scenes tool for better biomedical data discovery The new resource makes datasets more discoverable for life science communi...
19/05/2023
May 15, 2023
Scripps Research neuroscientist Hollis Cline elected to American Academy of Arts and Sciences Cline is recognized for her discoveries about the role of sensory ...
19/05/2023
May 18, 2023
Scripps Research's Skaggs Graduate School awards doctoral degrees to 31st graduating class Commencement ceremony will be livestreamed via Zoom and on instit...
13/05/2023
May 12, 2023
A better route to benzocyclobutenes, sought-after building blocks for drugs Scripps Research chemists devise a new, C-H activation-based method for the synthesi...
09/05/2023
May 08, 2023
Renowned Scripps Research professor Jeffery Kelly elected to National Academy of Sciences Kelly's groundbreaking work on protein misfolding has led to thera...
28/04/2023
April 27, 2023
Mirror-image molecules pave new path for cancer drug discovery By comparing how mirror image versions of small molecules impact clusters of proteins, Scripps R...
22/04/2023
April 21, 2023
How alcohol consumption contributes to chronic pain A Scripps Research team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and...
21/04/2023
April 20, 2023
Xin Jin receives dual awards to study autism risk genes in neurodevelopment Major grants from the National Institutes of Health and California Institute for Reg...
20/04/2023
April 19, 2023
Trim the sugar: New HIV vaccine design improves immune response Scripps Research vaccine candidate headed for clinical trials. April 19, 2023 LA JOLLA, CA A...
18/04/2023
April 17, 2023
Therapeutic can seek and destroy potent opioid to treat overdoses Scripps Research chemists developed a new biologic to work against the synthetic opioid carfen...
07/03/2023
March 06, 2023
How heavy alcohol consumption increases brain inflammation The findings by a Scripps Research team point toward a potential new drug target for treating alcohol...
02/03/2023
March 01, 2023
Scientists find human antibodies that can block multiple coronaviruses including SARS-CoV-2 Results from a Scripps Research and UNC team pave the way for a vacc...
28/02/2023
February 28, 2023
$10 million grant funds Scripps Research Alcohol Research Center through its 50th year The five-year grant supports research into the neurobiology of alcohol us...
28/02/2023
February 27, 2023
Immune system drug shows promise in treating alcohol use disorder, a Scripps Research clinical trial reports Scientists at Scripps Research found that apremilas...